Debate Over Breast Screening to Intensify After New BMJ Study

AuntMinnie | A research paper published on Thursday by the British Medical Journal has cast fresh doubt on the value of breast screening by suggesting that declining mortality rates are due more to improvements in treatment and the efficiency of healthcare systems than mammography screening.

“A growing number of people are asking questions about the evidence behind screening. We have to get rid of the infatuation with mammography and take a look at the hard facts,” said lead author Dr. Philippe Autier, research director at the International Prevention Research Institute in Lyon, France. “Our findings don’t support the mass screening of women and show that screening by itself has little detectable impact on mortality due to breast cancer.”

It’s time for radiology to end its infatuation with mammography, according to Dr. Philippe Autier.In an exclusive interview with AuntMinnieEurope.com, he advised radiologists to give much greater consideration to other emerging diagnostic methods, particularly MRI, although he conceded that worries persist about breast MRI‘s cost-effectiveness.

Autier also urged decision makers to look more closely at how breast screening is organized and implemented. He noted that huge differences exist in how screening is performed across Europe, and there is a particularly serious shortage of reliable data in both France and Germany. He added that he was disappointed himself about the findings, and he was prepared for a strong reaction from the supporters of breast screening.

Autier and his co-authors from France, the U.K., and Norway studied statistics from the World Health Organization (WHO) mortality database on cause of death between 1980 and 2006, as well as data sources on risk factors for breast cancer death, mammography screening, and cancer treatment. They found that from 1989 to 2006, deaths from breast cancer fell by 29% in Northern Ireland, 26% in the Republic of Ireland, 25% in the Netherlands, 20% in Belgium, 25% in Flanders, 16% in Sweden, and 24% in Norway (BMJ, July 28, 2011).

These trends in breast cancer mortality rates varied little between countries where women had been screened by mammography for a considerable time, compared with those where women were largely unscreened during that same period, the authors wrote. Furthermore, the greatest reductions were in women ages 40 to 49, regardless of the availability of screening in this age group.

From 1965 to 1980, cervical cancer mortality fell earlier and more strongly in Nordic countries that implemented nationwide screening programs, compared with those that delayed screening. Autier’s team used a similar approach to compare trends in breast cancer mortality within three pairs of European countries: Northern Ireland versus the Republic of Ireland, the Netherlands versus Belgium and Flanders, and Sweden versus Norway.

The researchers expected a reduction in breast cancer mortality would appear sooner in countries with earlier implementation of screening. Countries of each pair had similar healthcare services and level of risk factors for breast cancer mortality, but were different in that mammography screening was implemented about 10 to 15 years later in the second country of each pair.

“The contrast between the time differences in implementation of mammography screening and the similarity in reductions in mortality between the country pairs suggest that screening did not play a direct part in the reductions in breast cancer mortality,” they wrote. “Improvements in treatment and in the efficiency of healthcare systems may be more plausible explanations.”

Breast cancer mortality in the paired European countries with similar socioeconomic status and access to treatment was comparable after 1989, despite the 10 to 15 year difference in mammography screening implementation. The downward trends in mortality started before or shortly after the implementation of the screening program. The researchers also found the greatest reductions were in women ages 40 to 49, regardless of the availability of screening in this age group; reductions in women ages 70 to 79 were highly variable and did not correlate with the timing of screening in younger age groups.

Autier published another article in the BMJ last August about disparities in breast cancer mortality trends between 30 European countries (BMJ, May 2010, Vol. 341, pp. c3620). In a retrospective trend analysis of the WHO mortality database, he found that changes in breast cancer mortality after 1988 varied widely between European countries. Women younger than 50 showed the greatest reductions in mortality, and in countries where screening for that age is uncommon. The increasing mortality in some central European countries reflects avoidable mortality, according to the article.

Read more on AuntMinnie.com.



Kyle Henneberry, M.D.

Associate Chief Medical Officer
Dr. Kyle Henneberry is a radiologist, health-tech innovator and one of the founders and principals of Direct Radiology. A native of Spokane, Washington, he graduated with honors in Biomedical Engineering from Northwestern University, received his medical degree from Case Western Reserve University in Cleveland, Ohio, and completed radiology residency at the University of Colorado. Dr. Henneberry has United States, Europe, Australia, and New Zealand.

Jerry Lee

Chief Technology Officer

Jerry Lee has over 25 years of experience in healthcare IT. and has been with ONRAD since 2013. As the CTO, he is responsible for developing the organization’s technology strategy including IT infrastructure, application development, data analytics, cybersecurity and overall risk management. Lee’s focus is on strategic road mapping, leveraging emerging technologies and business intelligence to automate, streamline and optimize business processes. He previously worked as a senior healthcare IT consultant, where he implemented best practices, policies & procedures, and risk mitigation strategies for a variety of clients. He also previously worked as the Business Intelligence and Analytics Project Manager for a leading healthcare SaaS organization. He graduated with a B.S. from the University of California, Irvine.

Leandra Hutchinson

President, Direct Radiology

Leandra Hutchinson joined ONRAD alongside the acquisition of Direct Radiology in December 2024. Hutchison has broad experience in the healthcare industry, spending her career in healthcare technology and innovation. Prior to joining Direct Radiology in 2019, Leandra was the co-founder and Vice President of Operations of a health-tech company specializing in radiology analytics and healthcare asset management. Previously, Leandra worked in marketing, strategy, and operations roles for more than 10 years at a $7B integrated delivery system of hospitals and medical centers with more than 900 employed physicians. Hutchison earned her Bachelor’s degree from Kent State University and graduate certificate in health care policy and administration and MBA from the University of Toledo.

Ron Jackson

President, AllRads

Ron Jackson serves as President of AllRads at ONRAD, bringing over 30 years of comprehensive healthcare leadership across the provider, payer, and technology landscape. With deep expertise in radiology, he has spent more than 25 years in revenue cycle management, operations, finance, and practice management roles at leading organizations including HBOC, Per-Se Technologies, McKesson, and Zotec Partners. At ONRAD, Jackson leads day-to-day operations and strategic execution of AllRads, drawing on his cross-functional experience to drive efficiency, scalability, and growth. His 360-degree perspective of the healthcare ecosystem uniquely positions him to align organizational strategy with market dynamics in teleradiology and imaging services.

Alix Vincent, M.D.

Chief Medical Officer

Dr. Alix Vincent was one of the founding physicians at ONRAD. With over 26 years of radiology leadership experience, Dr. Vincent oversees medical staff activities, including patient safety, quality, and risk management initiatives. He manages ONRAD’s Regional Medical Directors, evaluates staff physicians, and drives clinical improvements to enhance physician alignment within the organization. Additionally, Dr. Vincent leads medical operations and played a key role in developing the company’s PACS and RIS Network capabilities. He previously served as Chief Radiologist and Chairman of the Radiology Department at Riverside Regional Medical Center. Dr. Vincent holds an M.D. in Radiology from Loma Linda University.

Lyn Mize

Chief Financial Officer

Lyn Mize serves as Chief Financial Officer at ONRAD, a role she has held since June 2022. With over two decades of experience in financial leadership, Mize has held CFO positions at various healthcare organizations, including Sunset Media Entertainment and Oncology Convergence, Inc. She also served as Vice President of Accounting at Health Choice and System Director of Accounting at Scottsdale Healthcare. Mize has a strong background in financial management, having worked with Banner Health and Greeley Medical Clinic, where she provided financial leadership for multi-specialty clinics and physician networks. Mize holds extensive expertise in driving financial performance and strategic growth across the healthcare sector and has a B.S. from DeVry University and a Masters from Grand Canyon University.

Dave Engert

President & CEO

Dave Engert started at Onrad as President and CEO in 2017. Engert is a seasoned healthcare executive with over 35 years of experience and a proven track record of leading and transforming healthcare technology organizations to drive growth and improve operational and financial performance. He previously served as President and CEO of Nighthawk Radiology, the largest teleradiology provider, and led its successful sale to vRad. Engert also held the role of President and CEO of Quality Care Solutions (QCSI), a leading provider of health insurance software, which was sold to Trizetto. Additionally, he has held leadership roles at McKesson, HBOC, and other notable companies and invested in several healthcare technology ventures. Engert holds a B.S. in Industrial Engineering from Louisiana State University.